Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Labcorp Holdings Inc. proporciona servicios de laboratorio. Opera en los segmentos de Laboratorios de Diagnóstico y Servicios de Laboratorio Biofarmacéutico. La empresa ofrece diversas pruebas, como análisis de química sanguínea, análisis de orina, recuentos de células sanguíneas, pruebas de tiroides, pruebas de Papanicolaou, hemoglobina A1C, PSA, pruebas de enfermedades de transmisión sexual, pruebas de vitamina D, cultivos y procedimientos de microbiología, y pruebas de abuso de alcohol y otras sustancias.
Traducido automáticamente
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | $14.3B | $14.0B | $13.0B | $12.2B | $11.9B | $13.1B | $14.0B | $11.6B | $11.3B | $10.4B | $9.6B | $8.7B | $6.0B | $5.8B | $5.7B | $5.5B | $5.0B | $4.7B | $4.5B | $4.1B | $3.6B |
| Beneficio bruto | $4.0B | $3.7B | $3.6B | $3.4B | $3.7B | $5.0B | $5.0B | $3.3B | $3.2B | $3.5B | $3.2B | $2.9B | $2.2B | $2.2B | $2.2B | $2.3B | $2.1B | $2.0B | $1.9B | $1.7B | $1.5B |
| % de margen bruto | 27.9% | 26.8% | 27.9% | 27.7% | 31.3% | 38.0% | 35.4% | 28.1% | 28.0% | 33.2% | 33.0% | 33.5% | 36.6% | 38.3% | 39.7% | 41.0% | 41.9% | 42.0% | 41.6% | 41.6% | 42.6% |
| Ingresos operativos (EBIT) | $1.6B | $1.5B | $1.1B | $726M | $1.4B | $3.0B | $2.4B | $1.3B | $1.3B | $1.4B | $1.3B | $1.0B | $910M | $991M | $1.0B | $948M | $979M | $936M | $843M | $777M | $697M |
| % de margen operativo | 11.3% | 10.9% | 8.3% | 6.0% | 12.1% | 23.2% | 17.5% | 11.5% | 11.7% | 13.1% | 13.6% | 11.6% | 15.1% | 17.1% | 18.1% | 17.1% | 19.6% | 19.9% | 18.7% | 19.1% | 19.4% |
| Ingresos netos | $1.0B | $876M | $746M | $418M | $1.3B | $2.4B | $1.6B | $824M | $884M | $1.3B | $732M | $437M | $511M | $574M | $583M | $520M | $558M | $543M | $464M | $477M | $432M |
| % de margen neto | 7.0% | 6.3% | 5.7% | 3.4% | 10.8% | 18.1% | 11.1% | 7.1% | 7.8% | 12.2% | 7.6% | 5.0% | 8.5% | 9.9% | 10.3% | 9.4% | 11.2% | 11.6% | 10.3% | 11.7% | 12.0% |
| EBITDA | $2.2B | $2.0B | $1.8B | $1.3B | $2.0B | $3.7B | $3.3B | $2.1B | $2.1B | $1.8B | $1.8B | $1.6B | $1.2B | $1.2B | $1.3B | $1.2B | $1.2B | $1.1B | $1.0B | $990M | $853M |
| Beneficio por acción (EPS) | $12.09 | $10.46 | $8.84 | $4.77 | $13.96 | $24.38 | $15.88 | $8.35 | $8.61 | $12.21 | $7.02 | $4.34 | $5.92 | $6.25 | $5.99 | $5.11 | $5.30 | $4.98 | $4.10 | $3.93 | $3.24 |
| Acciones en circulación (M) | 82M | 84M | 84M | 88M | 92M | 98M | 98M | 99M | 103M | 104M | 104M | 101M | 86M | 92M | 97M | 102M | 105M | 109M | 113M | 121M | 133M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de LH. /companies/us/LH
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms